Gland Pharma Limited has informed the Exchange about Copy of Newspaper Publication
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has submitted copies of newspaper advertisements that published its Unaudited Financial Results for the quarter and half year ended September 30, 2025 (Q2FY26). The Board of Directors approved these standalone and consolidated results at a meeting held on November 3, 2025. The advertisements were published in English (Business Standard, Hyderabad edition) and Telugu newspapers, as required under SEBI's Listing Regulations. The signed communication was issued by Srinivas Sadu, Executive Chairman. The company has also directed investors to view full results on its website and on BSE/NSE portals.
This is a routine regulatory compliance filing — no new financial numbers or strategic updates beyond what was already disclosed in the Q2FY26 results announcement. Shareholders should refer to the actual results filing for earnings, revenue, and margin details.